Presentation Information

[MSY3-1]PSMA Theranostics in Prostate Cancer: An Introduction from Molecular Imaging to Targeted Radioligand Therapy and Future Clinical Perspectives

Alexis Vrachimis (European Association of Nuclear Medicine (EANM))